Back to Science
Research and scientific data
In vitro activity of a novel compound, Mul-1867, against clinically significant fungi Candida spp. and Aspergillus spp.

International Journal of Antimicrobial Agents (2017)

Study of Mul-1867, a drug candidate for inhalation therapy of pulmonary exacerbations in patients with cystic fibrosis against mixed infections caused by clinical isolates of P. aeruginosa, S. aureus and C. albicans in murine lung infection model.

Journal of Cystic Fibrosis (2016)

Quick links
Contact Us
TGV-Biomed Headquarters
423 West 127th street,
New York, NY, 10027

Phone: 646 617 30 88
tets@tgvlabs.com
How can we help you?
Contact Us Today
© Copyright TGV-inhalonix 2016. All rights reserved.